PDS Biotechnology

PDS Biotechnology Corporation is a biopharmaceutical company. It develops immunotherapies for cancer and other infectious diseases. The company’s products are used for the prevention and treatment of cervical cancer, ovarian cancer, melanoma, leukemia, pancreatic cancer, oral cancer, multiple myeloma, anal cancer, vulvar cancer, and penile cancer. The company offers PDS0101 for the treatment of HPV-related cancers, a pandemic influenza vaccine PDS0102, and PDS0103, a series of immunotherapy products targeting non-viral cancers. PDS Biotech collaborates with leading cancer research institutions to advance clinical testing of PDS Biotech products across various cancers.